Polyposis Syndromes

Textbook of Gastroenterology, Fifth Edition

Volumn 1, Issue , 2009, Pages 1640-1668

  Burt, Randall W ^a,b   Jacoby, Russell F ^c,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Familial adenomatous polyposis; Miscellaneous noninherited polyposis syndromes; MUTYH gene associated polyposis; Polyposis conditions arising from lymphoid tissue; Polyposis syndromes; Polyposis syndromes with inflammatory polyps; Polyposis syndromes with neural polyp histology; Polyposis syndromes multiple gastrointestinal (GI) polyps in lumen; Syndromes with hamartomatous polyps

Indexed keywords

EID: 78649527195     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303254.ch64     Document Type: Chapter

References (322)

1. Bussey HJR. Familial Polyposis Coli. Family Studies, Histopathology, Differential Diagnosis and Results of Treatment. Baltimore: Johns Hopkins University Press, 1975.
2. Gardner EJ, Burt RW, Freston JW. Gastrointestinal polyposis: syndromes and genetic mechanisms. West J Med 1980; 132: 488.
3. Lockhart-Mummery JP, Dukes CE. Familial adenomatosis of colon and rectum. Lancet 1939; 237: 586.
4. Jarvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992; 33: 357.
5. Bulow S, Faurschou Nielsen T, Bulow C, et al. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis 1996; 11: 88.
6. Bisgaard ML, Fenger K, Bulow S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3: 121.
7. Bjork J, Akerbrant H, Iselius L, et al. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scand J Gastroenterol 1999; 34: 1230.
8. Iwama T, Tamura K, Morita T, et al. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004; 9: 308.
9. Aretz S, Uhlhaas S, Caspari R, et al. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 2004; 12: 52.
10. Chung DC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 2000; 119: 854.
11. Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000; 18: 1967.
12. Nathke I. APC at a glance. J Cell Sci 2004; 117: 4873.
13. Yamashita YM, Jones DL, Fuller MT. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science 2003; 301: 1547.
14. Etienne-Manneville S, Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 2003; 421: 753.
15. Flintoff KJ, Sheridan E, Turner G, et al. Submicroscopic deletions of the APC gene: a frequent cause of familial adenomatous polyposis that may be overlooked by conventional mutation scanning. J Med Genet 2001; 38: 129.
16. Aretz S, Stienen D, Uhlhaas S, et al. Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 2005; 42: 185.
17. Michils G, Tejpar S, Thoelen R, et al. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 2005; 25: 125.
18. Beroud C, Collod-Beroud G, Boileau C, et al. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 2000; 15: 86.
19. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 1993; 2: 425.
20. Groves C, Lamlum H, Crabtree M, et al. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 2002; 160: 2055.
21. Nagase H, Miyoshi Y, Horii A, et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 1992; 52: 4055.
22. Li G, Tamura K, Yamamoto Y, et al. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management. J Exp Clin Canc Res 1999; 18: 519.
23. Jarvinen HJ, Peltomaki P. The complex genotype-phenotype relationship in familial adenomatous polyposis. Eur J Gastroenterol Hepatol 2004; 16: 5.
24. Sieber OM, Lamlum H, Crabtree MD, et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 2002; 99: 2954.
25. Crabtree MD, Fletcher C, Churchman M, et al. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases. Gut 2004; 53: 271.
26. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101: 385.
27. Lamlum H, Al Tassan N, Jaeger E, et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 2000; 9: 2215.
28. Heppner Goss K, Trzepacz C, Tuohy TM, et al. Attenuated APC alleles produce functional protein from internal translation initiation. Proc Natl Acad Sci U S A 2002; 99: 8161.
29. Olschwang S, Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75: 959.
30. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4: 337.
31. Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57: 1151.
32. Bisgaard ML, Bulow S. Familial adenomatous polyposis (FAP): Genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 2006; 140: 200.
33. Bertario L, Russo A, Sala P, et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 2003; 21: 1698.
34. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997; 17: 79.
35. White RL. Excess risk of colon cancer associated with a polymorphism of the APC gene? Cancer Res 1998; 58: 4038.
36. Woodage T, King SM, Wacholder S, et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998; 20: 62.
37. Rozen P, Shomrat R, Strul H, et al. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 1999; 116: 54.
38. Fidder HH, Figer A, Geva R, et al. Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am J Gastroenterol 2005; 100: 1376.
39. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121: 198.
40. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003; 124: 1574.
41. Lindor NM. Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes. Clin Gastroenterol Hepatol 2004; 2: 366.
42. Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005; 128: 1696.
43. Renkonen ET, Nieminen P, Abdel-Rahman WM, et al. Adenomatous polyposis families that screen APC mutation-negative by conventional methods are genetically heterogeneous. J Clin Oncol 2005; 23: 5651.
44. Meuller J, Kanter-Smoler G, Nygren AO, et al. Identification of genomic deletions of the APC gene in familial adenomatous polyposis by two independent quantitative techniques. Genet Test 2004; 8: 248.
45. Moisio AL, Jarvinen H, Peltomaki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut 2002; 50: 845.
46. Laken SJ, Papadopoulos N, Petersen GM, et al. Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci U S A 1999; 96: 2322.
47. American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility. J Clin Oncol 2003; 21: 2397.
48. Solomon CH, Pho LN, Burt RW. Current status of genetic testing for colorectal cancer susceptibility. Oncology (Huntingt) 2002; 16: 161; discussion 176, 179.
49. Trimbath JD, Giardiello FM. Genetic testing and counselling for hereditary colorectal cancer. Aliment Pharmacol Ther 2002; 16: 1843.
50. Wong N, Lasko D, Rabelo R, et al. Genetic counseling and interpretation of genetic tests in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2001; 44: 271.
51. Codori AM, Zawacki KL, Petersen GM, et al. Genetic testing for hereditary colorectal cancer in children: Long-term psychological effects. Am J Med Genet 2003; 116: 117.
52. Geller G, Botkin JR, Green MJ, et al. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA 1997; 277: 1467.
53. Giardiello FM, Brensinger JD, Petersen GM. American Gastroenterological Association Medical Position Statement: Hereditary Colorectal Cancer and Genetic Testing. Gastroenterology 2001; 121: 195.
54. Kmietowicz Z. UK clinic allowed to screen embroys for rare bowel cancer. Br Med J 2004; 329: 1061.
55. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991; 100: 1658.
56. Friedl W, Caspari R, Sengteller M, et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001; 48: 515.
57. Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106: 1542.
58. Roncucci L, Stamp D, Medline A, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22: 287.
59. Bulow S. Results of national registration of familial adenomatous polyposis. Gut 2003; 52: 742.
60. Debinski HS, Love S, Spigelman AD, et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996; 110: 1028.
61. Jang YS, Steinhagen RM, Heimann TM. Colorectal cancer in familial adenomatous polyposis. Dis Colon Rectum 1997; 40: 312.
62. Burt RW. Gastric fundic gland polyps. Gastroenterology 2003; 125: 1462.
63. Bulow S, Bjork J, Christensen IJ, et al. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004; 53: 381.
64. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol 2003; 36: 399.
65. Zwick A, Munir M, Ryan CK, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 1997; 113: 659.
66. Hofgartner WT, Thorp M, Ramus MW, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999; 94: 2275.
67. Attard TM, Giardiello FM, Argani P, et al. Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr 2001; 32: 215.
68. Wu TT, Kornacki S, Rashid A, et al. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 1998; 22: 293.
69. Bertoni G, Sassatelli R, Nigrisoli E, et al. Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol 1999; 31: 192.
70. Abraham SC, Nobukawa B, Giardiello FM, et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol 2001; 158: 1005.
71. Sekine S, Shibata T, Yamauchi Y, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch 2002; 440: 381.
72. Abraham SC, Nobukawa B, Giardiello FM, et al. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 2000; 157: 747.
73. Nakamura S, Matsumoto T, Kobori Y, et al. Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut 2002; 51: 485.
74. Sawada T, Muto T. Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis. Gastrointest Endosc Clin N Am 1997; 7: 99.
75. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998; 85: 742.
76. Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2: 783.
77. Groves CJ, Saunders BP, Spigelman AD, et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002; 50: 636.
78. Saurin JC, Gutknecht C, Napoleon B, et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 2004; 22: 493.
79. Bjork J, Akerbrant H, Iselius L, et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001; 121: 1127.
80. Spigelman AD, Phillips RKS. The Upper Gastrointestinal Tract. In: Phillips RKS, Spigelman AD, Thomason JPS (eds). Familial Adenomatous Polyposis and Other Syndromes. London: Edward Arnold, 1994: 106.
81. Tytgat GN. Surveillance of familial adenomatous polyposis patients after ileorectal anastomosis or ileoanal pouch anastomosis. Gastrointest Endosc Clin N Am 1997; 7: 111.
82. Kurtz RC, Sternberg SS, Miller HH, et al. Upper gastrointestinal neoplasia in familial polyposis. Dig Dis Sci 1987; 32: 459.
83. Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 1: 1149.
84. Walsh N, Qizilbash A, Banerjee R, et al. Biliary neoplasia in Gardner's syndrome. Arch Pathol Lab Med 1987; 111: 76.
85. Gardner EJ, Plenk HP. Hereditary pattern for multiple osteomas in a family group. Am J Hum Genet 1952; 4: 31.
86. Gardner EJ. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermoid cysts. Am J Hum Genet 1962; 14: 376.
87. Bilkay U, Erdem O, Ozek C, et al. Benign osteoma with Gardner syndrome: review of the literature and report of a case. J Craniofac Surg 2004; 15: 506.
88. Brett MCA, Hershman MJ, Glazer G. Other manifestations of familial adenomatous polyposis. In: Phillips RKS, Spigelman AD, Thomason JPS (eds). Familial Adenomatous Polyposis and Other Syndromes. London: Edward Arnold, 1994: 143.
89. Takeuchi T, Takenoshita Y, Kubo K, et al. Natural course of jaw lesions in patients with familial adenomatosis coli (Gardner's syndrome). Int J Oral Maxillofac Surg 1993; 22: 226.
90. Giardiello FM, Offerhaus GJ, Traboulsi EI, et al. Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut 1991; 32: 1170.
91. Offerhaus GJ, Levin LS, Giardiello FM, et al. Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer. Gastroenterology 1987; 93: 490.
92. Kubo K, Miyatani H, Takenoshita Y, et al. Widespread radiopacity of jaw bones in familial adenomatosis coli. J Cranio Maxill Surg 1989; 17: 350.
93. Oku T, Takayama T, Sato Y, et al. A case of Gardner syndrome with a mutation at codon 1556 of APC: a suggested case of genotype-phenotype correlation in dental abnormality. Eur J Gastroenterol Hepatol 2004; 16: 101.
94. Gardner EJ, Richards RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953; 5: 139.
95. Sener SF, Miller HH, DeCosse JJ. The spectrum of polyposis. Surg Gynecol Obstet 1984; 159: 525.
96. Bussey HJ, Veale AM, Morson BC. Genetics of gastrointestinal polyposis. Gastroenterology 1978; 74: 1325.
97. Leppard BJ. Epidermoid cysts and polyposis coli. Proc R Soc Med 1974; 67: 1036.
98. Oldfield MC. The association of familial polyposis of the colon with multiple sebaceous cysts. Br J Surg 1954; 41: 534.
99. Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001; 92: 1259.
100. Clark SK, Neale KF, Landgrebe JC, et al. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999; 86: 1185.
101. Farmer KCR, Hawley PR, Phillips RKS. Desmoid disease. In: Phillips RKS, Spigelman AD, Thomason JPS (eds). Familial Adenomatous Polyposis and Other Polyposis Syndromes. London: Edward Arnold, 1994: 128.
102. Heiskanen I, Jarvinen HJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996; 11: 157.
103. Sturt NJH, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004; 53: 1832.
104. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994; 35: 377.
105. Bertario L, Russo A, Sala P, et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001; 95: 102.
106. Soravia C, Berk T, McLeod RS, et al. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363.
107. Pho LN, Coffin CM, Burt RW. Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion. Fam Cancer 2005; 4: 135.
108. Clark SK, Smith TG, Katz DE, et al. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg 1998; 85: 970.
109. Eccles DM, van der Luijt R, Breukel C, et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996; 59: 1193.
110. Scott RJ, Froggatt NJ, Trembath RC, et al. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 1996; 5: 1921.
111. Wehrli BM, Weiss SW, Yandow S, et al. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol 2001; 25: 645.
112. Middleton SB, Frayling IM, Phillips RK. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000; 82: 827.
113. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998; 153: 709.
114. Giarola M, Wells D, Mondini P, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer 1998; 78: 582.
115. Traboulsi EI, Krush AJ, Gardner EJ, et al. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med 1987; 316: 661.
116. Tourino R, Conde-Freire R, Cabezas-Agricola JM, et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol 2004; 25: 101.
117. Painter TA, Jagelman DG. Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 1985; 55: 2001.
118. Marchesa P, Fazio VW, Church JM, et al. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 1997; 40: 1023.
119. Smith TG, Clark SK, Katz DE, et al. Adrenal masses are associated with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 1739.
120. Giardiello FM, Hamilton SR, Krush AJ, et al. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology 1993; 105: 1550.
121. Valanzano R, Curia MC, Aceto G, et al. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour. Gut 2005; 54: 1046.
122. Young J, Barker M, Robertson T, et al. A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis. J Clin Pathol 2002; 55: 230.
123. Maire F, Hammel P, Terris B, et al. Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut 2002; 51: 446.
124. Cetta F, Montalto G, Gori M, et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 2000; 85: 286.
125. Giardiello FM, Offerhaus GJA, Krush AJ, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34: 1394.
126. Truta B, Allen BA, Conrad PG, et al. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer 2003; 2: 95.
127. Giardiello FM, Petersen GM, Brensinger JD, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 1996; 39: 867.
128. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005; 147: 263.
129. Trimbath JD, Griffin C, Romans K, et al. Attenuated familial adenomatous polyposis presenting as ampullary adenocarcinoma. Gut 2003; 52: 903.
130. Turcot J, Despres J-P, St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon. Dis Colon Rectum 1959; 2: 465.
131. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332: 839.
132. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 1997; 15: 2744.
133. Burt RW, Leppert MF, Slattery ML, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004; 127: 444.
134. Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002; 45: 127; discussion 134.
135. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2: 43.
136. Cao Y, Pieretti M, Marshall J, et al. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol 2002; 97: 1822.
137. Heiskanen I, Luostarinen T, Jarvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 1284.
138. Arvanitis ML, Jagelman DG, Fazio VW, et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639.
139. Belchetz LA, Berk T, Bapat BV, et al. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996; 39: 384.
140. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993; 36: 1059.
141. Nugent KP, Spigelman AD, Phillips RK. Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996; 83: 1121.
142. Bjork JA, Akerbrant HI, Iselius LE, et al. Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis Colon Rectum 2000; 43: 1719.
143. Burt RW. Colon cancer screening. Gastroenterology 2000; 119: 837.
144. Guillem JG, Smith AJ, Culle J, et al. Gastrointestinal polyposis syndromes. Curr Probl Surg 1999; 36: 217.
145. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16: 63.
146. Attard TM, Cuffari C, Tajouri T, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 2004; 99: 681.
147. Burke C, Santisi J, Levinthal G, et al. The use of capsule endoscopy to detect small bowel polyps in patients with FAP. Fam Cancer 2003; 2: 34.
148. Parc YR, Olschwang S, Desaint B, et al. Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg 2001; 233: 360.
149. Groves CJ, Beveridge G, Swain DJ, et al. Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum 2005; 48: 816.
150. Ooi BS, Remzi FH, Gramlich T, et al. Anal transitional zone cancer after restorative proctocolectomy and ileoanal anastomosis in familial adenomatous polyposis: report of two cases. Dis Colon Rectum 2003; 46: 1418; discussion 1422.
151. Church J. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum 2005; 48: 1708.
152. Feinberg SM, Jagelman DG, Sarre RG, et al. Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis. Dis Colon Rectum 1988; 31: 169.
153. Morpurgo E, Vitale GC, Galandiuk S, et al. Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 2004; 8: 559.
154. Bülow C, Vasen H, Järvinen H, et al. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology 2000; 119: 1454.
155. Mills SJ, Chapman PD, Burn J, et al. Endoscopic screening and surgery for familial adenomatous polyposis: dangerous delays. Br J Surg 1997; 84: 74.
156. Fazio VW, Tekkis PP, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 2003; 238: 605; discussion 614.
157. Delaney CP, Fazio VW, Remzi FH, et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 2003; 238: 221.
158. Chapman JR, Larson DW, Wolff BG, et al. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch Surg 2005; 140: 534; discussion 539.
159. Olsen KO, Juul S, Bulow S, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003; 90: 227.
160. Parc Y, Piquard A, Dozois RR, et al. Long-term outcome of familial adenomatous polyposis patients after restorative coloproctectomy. Ann Surg 2004; 239: 378.
161. Kienle P, Z'Graggen K, Schmidt J, et al. Laparoscopic restorative proctocolectomy. Br J Surg 2005; 92: 88.
162. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635.
163. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313.
164. Nugent KP, Farmer KC, Spigelman AD, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618.
165. DuBois RN, Giardiello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am 1996; 25: 773.
166. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946.
167. Cruz-Correa M, Hylind LM, Romans KE, et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 2002; 122: 641.
168. Higuchi T, Iwama T, Yoshinaga K, et al. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003; 9: 4756.
169. Hallak A, Alon-Baron L, Shamir R, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci 2003; 48: 1998.
170. Giardiello FM, Yang VW, Hylind LM, et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002; 346: 1054.
171. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092.
172. Solomon SD, McMurray JJV, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352: 1071.
173. Giardiello FM, Casero RA Jr, Hamilton SR, et al. Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology 2004; 126: 425.
174. Giardiello FM, Hylind LM, Trimbath JD, et al. Oral contraceptives and polyp regression in familial adenomatous polyposis. Gastroenterology 2005; 128: 1077.
175. de Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J, et al. Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 2003; 90: 705.
176. Phillips RK, Wallace MH, Lynch PM, et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002; 50: 857.
177. Jacoby RF, Cole CE, Hawk ET, et al. Ursodeoxycholate/sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Gastroenterology 2004; 127: 838.
178. Zadorova Z, Dvofak M, Hajer J. Endoscopic therapy of benign tumors of the papilla of Vater. Endoscopy 2001; 33: 345.
179. Norton ID, Geller A, Petersen BT, et al. Endoscopic surveillance and ablative therapy for periampullary adenomas. Am J Gastroenterol 2001; 96: 101.
180. Desilets DJ, Dy RM, Ku PM, et al. Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications. Gastrointest Endosc 2001; 54: 202.
181. Cheng CL, Sherman S, Fogel EL, et al. Endoscopic snare papillectomy for tumors of the duodenal papillae. Gastrointest Endosc 2004; 60: 757.
182. Gallagher MC, Shankar A, Groves CJ, et al. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 2004; 91: 1157.
183. Healy JC, Reznek RH, Clark SK, et al. MR appearances of desmoid tumors in familial adenomatous polyposis. Am J Roentgenol 1997; 169: 465.
184. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, et al. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994; 74: 1270.
185. Middleton SB, Phillips RK. Surgery for large intra-abdominal desmoid tumors: report of four cases. Dis Colon Rectum 2000; 43: 1759; discussion 1762.
186. Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996; 83: 1494.
187. Bauernhofer T, Stoger H, Schmid M, et al. Sequential treatment of recurrent mesenteric desmoid tumor. Cancer 1996; 77: 1061.
188. Clark SK. Sulindac and tamoxifen in the treatment of desmoid tumours in patients with familial adenomatous polyposis. Colorectal Dis 2002; 4: 68.
189. Poritz LS, Blackstein M, Berk T, et al. Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors. Dis Colon Rectum 2001; 44: 1268.
190. Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003; 97: 1134.
191. Risum S, Bulow S. Doxorubicin treatment of an intra-abdominal desmoid tumour in a patient with familial adenomatous polyposis. Colorectal Dis 2003; 5: 585.
192. Mace J, Sybil Biermann J, Sondak V, et al. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002; 95: 2373.
193. Chatzipetrou MA, Tzakis AG, Pinna AD, et al. Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery 2001; 129: 277.
194. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MUTYH associated with somatic G: C→T: A mutations in colorectal tumors. Nat Genet 2002; 30: 227.
195. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MUTYH. N Engl J Med 2003; 348: 791.
196. Wang L, Baudhuin LM, Boardman LA, et al. MUTYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 2004; 127: 9.
197. Jo W-S, Bandipalliam P, Shannon KM, et al. Correlation of polyp number and family history of colon cancer with germline MUTYH mutations. Clin Gastroenterol H 2005; 3: 1022.
198. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MUTYH. Lancet 2003; 362: 39.
199. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MUTYH predispose to multiple colorectal adenoma and somatic G: C→T: A mutations. Hum Mol Genet 2002; 11: 2961.
200. Venesio T, Molatore S, Cattaneo F, et al. High frequency of MUTYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology 2004; 126: 1681.
201. Fleischmann C, Peto J, Cheadle J, et al. Comprehensive analysis of the contribution of germline MUTYH variation to early-onset colorectal cancer. Int J Cancer 2004; 109: 554.
202. Enholm S, Hienonen T, Suomalainen A, et al. Proportion and phenotype of MUTYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 2003; 163: 827.
203. Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005; 77: 112.
204. Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MUTYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96: 1631.
205. Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MUTYH, a base excision repair gene. Clin Gastroenterol Hepatol 2004; 2: 633.
206. Halford SE, Rowan AJ, Lipton L, et al. Germline mutations but not somatic changes at the MUTYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003; 162: 1545.
207. Lipton L, Halford SE, Johnson V, et al. Carcinogenesis in MUTYH-associated polyposis follows a distinct genetic pathway. Cancer Res 2003; 63: 7595.
208. Gismondi V, Bonelli L, Sciallero S, et al. Prevalence of the E1317Q variant of the APC gene in Italian patients with colorectal adenomas. Genet Test 2002; 6: 313.
209. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. A syndrome of diagnostic significance. N Engl J Med 1949; 241: 993.
210. Lim W, Olschwang S, Keller JJ, et al. Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 2004; 126: 1788.
211. McGarrity TJ, Kulin HE, Zaino RJ. Peutz-Jeghers syndrome. Am J Gastroenterol 2000; 95: 596.
212. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100: 476.
213. Amos CI, Keitheri-Cheteri MB, Sabripour M, et al. Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 2004; 41: 327.
214. Aretz S, Stienen D, Uhlhaas S, et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 2005; 26: 513.
215. Marignani PA. LKB1, the multitasking tumour suppressor kinase. J Clin Pathol 2005; 58: 15.
216. Amaro R, Diaz G, Schneider J, et al. Peutz-Jeghers syndrome managed with a complete intraoperative endoscopy and extensive polypectomy. Gastrointest Endosc 2000; 52: 552.
217. Parsi MA, Burke CA. Utility of capsule endoscopy in Peutz-Jeghers syndrome. Gastrointest Endosc Clin N Am 2004; 14: 159.
218. Burke CA, Santisi J, Church J, et al. The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol 2005; 100: 1498.
219. Ohmiya N, Taguchi A, Shirai K, et al. Endoscopic resection of Peutz-Jeghers polyps throughout the small intestine at double-balloon enteroscopy without laparotomy. Gastrointest Endosc 2005; 61: 140.
220. May A, Nachbar L, Ell C. Double-balloon enteroscopy (push-andpull enteroscopy) of the small bowel: feasibility and diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endosc 2005; 62: 62.
221. Udd L, Katajisto P, Rossi DJ, et al. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology 2004; 127: 1030.
222. Chow E, Macrae F. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol 2005; 20: 1634.
223. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 2002; 31: 1107.
224. Giardiello FM, Hamilton SR, Kern SE, et al. Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 1991; 66: 971.
225. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986; 10: 871.
226. Coburn MC, Pricolo VE, DeLuca FG, et al. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995; 2: 386.
227. Rozen P, Samuel Z, Brazowski E, et al. An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features. Fam Cancer 2003; 2: 1.
228. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary hemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363: 852.
229. Sayed MG, Ahmed AF, Ringold JR, et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 2002; 9: 901.
230. Friedl W, Uhlhaas S, Schulmann K, et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 2002; 111: 108.
231. Attard TM, Lynch HT. Diagnosis and management issues in pediatric patients with gastrointestinal polyps. Pract Gastroenterol 2003; 27: 57.
232. Aaltonen LA, Jass JR, Howe JR. Juvenile polyposis. In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours. Lyon: IARC Press, 2000: 130.
233. Wirtzfeld DA, Petrelli NJ, Rodriguez-Bigas MA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol 2001; 8: 319.
234. Jass JR, Williams CB, Bussey HJ, et al. Juvenile polyposis -a precancerous condition. Histopathology 1988; 13: 619.
235. Jarvinen H, Franssila KO. Familial juvenile polyposis coli; increased risk of colorectal cancer. Gut 1984; 25: 792.
236. Howe JR, Sayed MG, Ahmed AF, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 2004; 41: 484.
237. Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 2005; 294: 2465.
238. Pyatt RE, Pilarski R, Prior TW. Mutation screening in juvenile polyposis syndrome. J Mol Diagn 2006; 8: 84.
239. Handra-Luca A, Condroyer C, de Moncuit C, et al. Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A 2005; 138: 113.
240. Haramis AP, Begthel H, van den Born M, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004; 303: 1684.
241. He XC, Zhang J, Tong WG, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004; 36: 1117.
242. Woodford-Richens K, Bevan S, Churchman M, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 2000; 46: 656.
243. Hardwick JC, Van Den Brink GR, Bleuming SA, et al. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 2004; 126: 111.
244. Howe JR, Ringold JC, Hughes JH, et al. Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis. Surgery 1999; 126: 162.
245. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002; 51 (Suppl. 5): V21.
246. Oncel M, Church JM, Remzi FH, et al. Colonic surgery in patients with juvenile polyposis syndrome: a case series. Dis Colon Rectum 2005; 48: 49; discussion 55.
247. Brazowski E, Rozen P, Misonzhnick-Bedny F, et al. Characteristics of familial juvenile polyps expressing cyclooxygenase-2. Am J Gastroenterol 2005; 100: 130.
248. Eng C. Will the real Cowden syndrome please stand up?: revised diagnostic criteria. J Med Genet 2000; 37: 828.
249. Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004; 41: 323.
250. Turnbull MM, Humeniuk V, Stein B, et al. Arteriovenous malformations in Cowden syndrome. J Med Genet 2005; 42: e50.
251. Kato M, Mizuki A, Hayashi T, et al. Cowden's disease diagnosed through mucocutaneous lesions and gastrointestinal polyposis with recurrent hematochezia, unrevealed by initial diagnosis. Intern Med 2000; 39: 559.
252. Derrey S, Proust F, Debono B, et al. Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature. Surg Neurol 2004; 61: 447; discussion 454.
253. Robinson S, Cohen AR. Cowden disease and Lhermitte-Duclos disease: an update. Case report and review of the literature. Neurosurg Focus 2006; 20: E6.
254. Hendriks YM, Verhallen JT, van der Smagt JJ, et al. BannayanRiley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer 2003; 2: 79.
255. Erkek E, Hizel S, Sanly C, et al. Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome. J Am Acad Dermatol 2005; 53: 639.
256. Lowichik A, White FV, Timmons CF, et al. Bannayan-Riley-Ruvalcaba syndrome: spectrum of intestinal pathology including juvenile polyps. Pediatr Devel Pathol 2000; 3: 155.
257. Merks JH, de Vries LS, Zhou XP, et al. PTEN hamartoma tumour syndrome: variability of an entity. J Med Genet 2003; 40: e111.
258. Zhou X-P, Marsh DJ, Morrison CD, et al. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 2003; 73: 1191.
259. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003; 22: 183.
260. Isomoto H, Furusu H, Ohnita K, et al. Effect of Helicobacter pylori eradication on gastric hyperplastic polyposis in Cowden's disease. World J Gastroenterol 2005; 11: 1567.
261. Rozen P, Samuel Z, Brazowski E. A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol 2003; 98: 2317.
262. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998; 90: 1039.
263. Maertens O, Prenen H, Debiec-Rychter M, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006; 15: 1015.
264. Miettinen M, Fetsch JF, Sobin LH, et al. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006; 30: 90.
265. Hochberg FH, Dasilva AB, Galdabini J, et al. Gastrointestinal involvement in von Recklinghausen's neurofibromatosis. Neurology 1974; 24: 1144.
266. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract. Relation to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol 1994; 18: 250.
267. Artaza T, Garcia JF, Gonzalez C, et al. Simultaneous involvement of the jejunum and the colon by type-1 neurofibromatosis. Scand J Gastroenterol 1999; 34: 331.
268. Kim HR, Kim YJ. Neurofibromatosis of the colon and rectum combined with other manifestations of von Recklinghausen's disease: report of a case. Dis Colon Rectum 1998; 41: 1187.
269. Gallinger S, Aronson M, Shayan K, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004; 126: 576.
270. Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies and features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005; 4: 323.
271. Peczkowska M, Januszewicz A. Multiple endocrine neoplasia type 2. Fam Cancer 2005; 4: 25.
272. Marsh DJ, Mulligan LM, Eng C. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res 1997; 47: 168.
273. Bononi M, De Cesare A, Stella MC, et al. Isolated intestinal neurofibromatosis of colon. Single case report and review of the literature. Digest Liver Dis 2000; 32: 737.
274. Chadalavada R, Brown DK, Walker AN, et al. Cronkhite-Canada syndrome: sustained remission after corticosteroid treatment. Am J Gastroenterol 2003; 98: 1444.
275. Blonski WC, Furth EE, Kinosian BP, et al. A case of Cronkhite-Canada syndrome with taste disturbance as a leading complaint. Digestion 2005; 71: 201.
276. Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion 2005; 71: 199.
277. Yamaguchi K, Ogata Y, Akagi Y, et al. Cronkhite-Canada syndrome associated with advanced rectal cancer treated by a subtotal colectomy: report of a case. Surg Today 2001; 31: 521.
278. Burt R, Jass JR. Hyperplastic polyposis. In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours. Lyon: IARC Press, 2000: 135.
279. Ferrandez A, Samowitz W, DiSario JA, et al. Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 2004; 99: 2012.
280. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004; 99: 1779.
281. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004; 47: 2101.
282. Rashid A, Houlihan PS, Booker S, et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000; 119: 323.
283. Allibone RO, Nanson JK, Anthony PP. Multiple and recurrent inflammatory fibroid polyps in a Devon family ("Devon polyposis syndrome"): an update. Gut 1992; 33: 1004.
284. Ng KH, Mathur P, Kumarasinghe MP, et al. Cap polyposis: further experience and review. Dis Colon Rectum 2004; 47: 1208.
285. Esaki M, Matsumoto T, Kobayashi H, et al. Cap polyposis of the colon and rectum: an analysis of endoscopic findings. Endoscopy 2001; 33: 262.
286. Isomoto H, Urata M, Nakagoe T, et al. Proximal extension of cap polyposis confirmed by colonoscopy. Gastrointest Endosc 2001; 54: 388.
287. Oriuchi T, Kinouchi Y, Kimura M, et al. Successful treatment of cap polyposis by avoidance of intraluminal trauma: clues to pathogenesis. Am J Gastroenterol 2000; 95: 2095.
288. Oiya H, Okawa K, Aoki T, et al. Cap polyposis cured by Helicobacter pylori eradication therapy. J Gastroenterol 2002; 37: 463.
289. Bookman ID, Redston MS, Greenberg GR. Successful treatment of cap polyposis with infliximab. Gastroenterology 2004; 126: 1868.
290. Bastlein C, Burlefinger R, Holzberg E, et al. Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine. Endoscopy 1988; 20: 272.
291. Castellano G, Moreno D, Galvao O, et al. Malignant lymphoma of jejunum with common variable hypogammaglobulinemia and diffuse nodular hyperplasia of the small intestine. A case study and literature review. J Clin Gastroenterol 1992; 15: 128.
292. Atwell JD, Burge D, Wright D. Nodular lymphoid hyperplasia of the intestinal tract in infancy and childhood. J Pediatr Surg 1985; 20: 25.
293. Blackstone MO. Endoscopic Interpretation. Normal and Pathologic Appearances of the Gastrointestinal Tract. New York: Raven Press, 1984.
294. Lai Ping So A, Mayer L. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 1997; 8: 22.
295. Schwartz DC, Cole CE, Sun Y, et al. Diffuse nodular lymphoid hyperplasia of the colon: polyposis syndrome or normal variant? Gastrointest Endosc 2003; 58: 630.
296. Bharadhwaj G, Triadafilopoulos G. Endoscopic appearances of colonic lymphoid nodules: new faces of an old histopathological entity. Am J Gastroenterol 1995; 90: 946.
297. Nagasako K, Takemoto T. Endoscopy of the ileocecal area. Gastroenterology 1973; 65: 403.
298. Nagaoka S, Bandoh T, Takemura T. Lymphoid hyperplasia of the large intestine: a case report with immunohistochemical and gene analysis. Pathol Int 2000; 50: 750.
299. Foss HD, Stein H. Pathology of intestinal lymphomas. Recent Res Cancer 2000; 156: 33.
300. Ruskone-Fourmestraux A. Gastrointestinal lymphomas: the French experience of the Groupe D'etude des Lymphomes Digestifs (GELD). Recent Res Cancer 2000; 156: 99.
301. Tamura S, Ohkawauchi K, Yokoyama Y, et al. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol 2004; 39: 995.
302. Okazaki K. Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol 2004; 39: 1023.
303. Pals ST, Drillenburg P, Dragosics B, et al. Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine. Gastroenterology 1994; 107: 1519.
304. Endoh M, Hiraishi H, Terano A. Gastrointestinal: multiple lymphomatous polyposis. J Gastroenterol Hepatol 1999; 14: 937.
305. Mynster T, Hultberg B, Bulow S. Multiple lymphomatous polyposis of the colon and rectum. Scand J Gastroenterol 1994; 29: 545.
306. Ruskone-Fourmestraux A, Delmer A, Lavergne A, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'etude des Lymphomes Digestifs. Gastroenterology 1997; 112: 7.
307. Ko CW, Poon SK, Chow WK, et al. Primary low-grade, B-cell, mucosa-associated lymphoid tissue lymphoma presenting as lymphomatous polyposis. Gastrointest Endosc 1998; 48: 631.
308. Breslin NP, Urbanski SJ, Shaffer EA. Mucosa-associated lymphoid tissue (MALT) lymphoma manifesting as multiple lymphomatosis polyposis of the gastrointestinal tract. Am J Gastroenterol 1999; 94: 2540.
309. Hashimoto Y, Nakamura N, Kuze T, et al. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogenous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum Pathol 1999; 30: 581.
310. Hara Y, Nakamura N, Yatabe Y, et al. Intraclonal microheterogeneity of mucosa-associated lymphoid tissue lymphoma with a multiple lymphomatous polyposis appearance in the gastrointestinal tract. Pathol Int 2001; 51: 744.
311. Sakata Y, Iwakiri R, Sakata H, et al. Primary gastrointestinal follicular center lymphoma resembling multiple lymphomatous polyposis. Dig Dis Sci 2001; 46: 567.
312. Ogawa A, Fukushima N, Satoh T, et al. Primary intestinal T-cell lymphoma resembling lymphomatous polyposis: report of a case. Virchows Arch 2000; 437: 450.
313. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005; 105: 2274.
314. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239.
315. Freni SC, Keeman JN. Leiomyomatosis of the colon. Cancer 1977; 39: 263.
316. Spaun E, Nielsen L. Leiomyomatosis of the colon and mesentery: report of a case. Am J Gastroenterol 1986; 81: 385.
317. Vallaeys JH, Cuvelier CA, Bekaert L, et al. Combined leiomyomatosis of the small intestine and colon. Arch Pathol Lab Med 1992; 116: 281.
318. Santos-Briz A, Garcia JP, Gonzalez C, et al. Lipomatous polyposis of the colon. Histopathology 2001; 38: 81.
319. Brouland JP, Poupard B, Nemeth J, et al. Lipomatous polyposis of the colon with multiple lipomas of peritoneal folds and giant diverticulosis: report of a case. Dis Colon Rectum 2000; 43: 1767.
320. Tatsuguchi A, Fukuda Y, Moriyama T, et al. Lipomatosis of the small intestine and colon associated with intussusception in the ileocecal region. Gastrointest Endosc 1999; 49: 118.
321. Watanabe T, Kato K, Sugitani M, et al. A case of multiple lymphangiomas of the colon suggesting colonic lymphangiomatosis. Gastrointest Endosc 2000; 52: 781.
322. Attar A, Pocard M, Messing B. Pneumatosis cystoides intestinalis in primary intestinal pseudo-obstruction: a nonsurgical cause of pneumoperitoneum. Clin Gastroenterol Hepatol 2005; 3: A21.